ArticleClinical and translational allergy2023

Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.

Ramón Gimeno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.